Breast Implant Illness and BIA-ALCL Lawsuit: 2026 Guide

This article supports TortAdvisor’s
Breast Implant Lawsuit Research
and
Medical Device Lawsuits Hub.
For the broader lawsuit directory, visit
Medical Device Lawsuits Research.

Breast implant lawsuit: Patients considering a legal claim in 2026 may be researching Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), recalled textured implants, implant rupture, revision or explant surgery, or systemic symptoms commonly described as Breast Implant Illness (BII). These conditions do not all involve the same medical or legal evidence, so product identification, diagnosis, treatment records, implant history, causation evidence, and applicable filing deadlines can be important to an individual claim review.

Breast Implant Lawsuit and BIA-ALCL

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a type of non-Hodgkin lymphoma involving the immune system. It is not breast cancer.

According to the FDA, BIA-ALCL is generally found in the fluid or scar-tissue capsule surrounding a breast implant and occurs more frequently in patients who have had textured-surface implants than in patients with smooth-surface implants.

Potential signs reported in FDA materials can include persistent swelling around the implant, a mass or lump, or pain in the area surrounding the breast implant. These symptoms can develop after the surgical incision has healed and may occur years after implantation.

A legal claim involving BIA-ALCL may require detailed medical documentation, including pathology or biopsy confirmation, oncology records, operative reports, implant identification, explant or capsulectomy records, and evidence identifying the manufacturer and surface type of the implant.

Textured Implants and the Allergan BIOCELL Recall

Textured implant history is especially important in BIA-ALCL litigation. In July 2019, Allergan voluntarily recalled its BIOCELL textured breast implants and tissue expanders after the FDA requested the recall because of the associated BIA-ALCL risk.

The recall involved certain Natrelle and McGhan BIOCELL textured breast implants and tissue expanders. Smooth-surface implants were not part of that BIOCELL recall.

If you do not know which implant you received, useful sources for product identification can include:

• Breast implant identification card.
• Original operative report.
• Hospital or surgical-center records.
• Manufacturer stickers placed in the operative chart.
• Model, serial, or lot numbers.
• Plastic surgeon records.
• Explant or revision surgery records.

You can also review TortAdvisor’s
Breast Implant Recall Guide
for additional information about recalled textured products.

Understanding Breast Implant Illness Symptoms

Breast Implant Illness (BII) is a term used by patients and some clinicians to describe systemic symptoms reported after breast implantation. FDA states that BII is not currently recognized as a formal medical diagnosis and that there are no specific diagnostic tests or recognized criteria that definitively define the condition.

Symptoms reported to the FDA in connection with systemic breast implant complaints include:

• Chronic fatigue.
• Joint pain.
• Muscle pain.
• Memory or concentration problems commonly described as “brain fog.”
• Hair loss.
• Anxiety or depression.
• Skin rashes.
• Weight changes.
• Other systemic or autoimmune-like symptoms.

The FDA has received reports involving systemic symptoms with different types of implants, regardless of filling material, shape, or surface characteristics. However, the cause of these symptoms and the degree to which they are related to breast implants remain unclear.

Some patients report improvement after implant removal. FDA’s review of adverse-event reports includes patients who reported improvement following explantation, but those reports cannot by themselves establish how often improvement occurs or prove that implants caused the symptoms.

For more detailed discussion, see TortAdvisor’s
Breast Implant Illness and Silicone Toxicity Guide.

Other Breast Implant Complications

A breast implant claim is not necessarily limited to BIA-ALCL or systemic symptoms. Depending on the facts, patients may also seek review after experiencing serious device or surgical complications such as:

• Implant rupture or deflation.
• Silicone leakage or migration.
• Painful capsular contracture.
• Implant displacement or malposition.
• Persistent infection.
• Seroma or fluid accumulation.
• Revision surgery.
• Explant surgery.
• Scarring or disfigurement.
• Repeated reconstructive procedures.
• Other serious implant-related complications documented in medical records.

The presence of a complication does not automatically establish a product-liability claim. Attorneys typically must examine the product, warnings, implant history, medical causation, treatment, damages, applicable law, and potential defenses.

Breast Implant Litigation Status in 2026

Federal product-liability cases involving Allergan BIOCELL textured breast implants are coordinated in MDL 2921, In re: Allergan BIOCELL Textured Breast Implant Products Liability Litigation, in the U.S. District Court for the District of New Jersey.

Multidistrict litigation does not turn every plaintiff’s case into one class action. Instead, cases involving common factual issues can be coordinated for pretrial proceedings while individual plaintiffs retain claim-specific issues involving diagnosis, implant history, causation, damages, statutes of limitations, and other defenses.

The District of New Jersey maintains the official MDL 2921 case page and directs parties to PACER for the most current master-docket filings.

Patients should therefore be careful with articles that quote an old number of pending cases. The federal docket changes as cases are filed, transferred, resolved, dismissed, or otherwise administratively updated.

Who May Have a Breast Implant Injury Claim?

A potential breast implant lawsuit may warrant review when a patient has documented serious injury or treatment following implantation, particularly when the implant manufacturer and model can be identified.

Examples that may justify a closer legal review include:

• Confirmed BIA-ALCL diagnosis.
• History of an Allergan BIOCELL or another relevant textured implant.
• Explant or capsulectomy following a serious implant complication.
• Oncology treatment connected to BIA-ALCL.
• Implant rupture or significant leakage requiring additional surgery.
• Multiple revision procedures.
• Serious documented systemic symptoms followed by explantation or extensive treatment.
• Other significant implant complications resulting in medical expenses, lost income, or substantial long-term harm.

Eligibility cannot be determined from a diagnosis name alone. Product identification, causation, state law, timing, available defendants, prior settlements, and medical evidence can materially affect a claim.

Evidence and Records That May Matter

Breast implant product-liability claims are heavily dependent on medical and product identification evidence. Useful records may include:

• Implant identification card.
• Manufacturer, implant model, serial number, and lot number.
• Original implantation operative report.
• Hospital or surgery-center records.
• Pathology and biopsy reports.
• CD30 and other BIA-ALCL-related pathology documentation when applicable.
• Oncology records.
• Imaging studies.
• Explant and capsulectomy records.
• Revision or reconstructive surgery records.
• Photographs documenting complications when medically appropriate.
• Medical bills and insurance statements.
• Lost-income or disability records.
• A timeline showing symptom onset, diagnosis, and treatment.

If the removed implant, capsule, pathology specimen, or related medical evidence still exists, speak with your treating providers and attorney about appropriate preservation. Do not interfere with medical treatment or specimen handling for the purpose of a legal claim.

Breast Implant Settlement and Compensation Factors

There is no guaranteed breast implant settlement amount. Potential value depends on the individual medical and legal facts.

Factors that may affect claim evaluation include:

• Confirmed BIA-ALCL diagnosis.
• Stage and severity of disease.
• Implant manufacturer and surface type.
• Recall-related product identification.
• Biopsy or pathology evidence.
• Explant or capsulectomy surgery.
• Chemotherapy, radiation, or other oncology treatment when required.
• Additional reconstruction or revision surgery.
• Medical expenses.
• Lost wages or reduced earning ability.
• Scarring and physical limitations.
• Emotional and quality-of-life effects.
• Long-term monitoring or future medical needs.
• Strength of causation and product-liability evidence.
• Applicable state law and defenses.

For an educational estimate, use TortAdvisor’s
Breast Implant Settlement Calculator 2026.

You can also browse the
Breast Implant Lawsuit Research
for broader information about how injury claims are valued.

Breast Implant Lawsuit Filing Deadlines

Breast implant lawsuit deadlines vary by state and may depend on several dates, including implantation, symptom onset, diagnosis, discovery of a possible connection to the implant, recall information, explantation, or another legally relevant event.

Different claims and defendants can also be governed by different statutes of limitations or statutes of repose.

For that reason, an older implant does not automatically mean a claim is barred, and a recent diagnosis does not automatically mean unlimited time remains.

Important Medical Safety Information

A lawsuit page should not substitute for medical care. Patients who have symptoms or concerns about a breast implant should discuss them with a qualified healthcare professional.

FDA advises patients to be aware of BIA-ALCL symptoms and to seek medical evaluation for changes such as persistent swelling, pain, or a mass around the implant.

Patients without symptoms should not remove an implant solely because they saw that a product was recalled without first speaking with a healthcare professional. In connection with the Allergan BIOCELL recall, FDA did not recommend routine removal of recalled textured implants in asymptomatic patients because surgical removal itself carries risks.

Do not stop treatment, delay oncology care, or schedule implant removal based on legal information from this page.

Related TortAdvisor Guides and Tools

FDA and Federal Court Sources

Breast Implant Lawsuit FAQ

What is BIA-ALCL?

BIA-ALCL is a type of non-Hodgkin lymphoma involving the immune system, not breast cancer. FDA reports that it develops more frequently in patients with textured breast implants and is usually found in the fluid or scar tissue surrounding an implant.

Are all textured breast implants recalled?

No. The major 2019 U.S. recall discussed in breast implant litigation involved specific Allergan BIOCELL textured breast implants and tissue expanders. Product identification is important because not every textured implant is the same product.

Should I remove a recalled textured implant if I have no symptoms?

FDA has not recommended routine removal of Allergan BIOCELL textured implants in asymptomatic patients because removal surgery has its own risks. Patients should discuss their individual situation with a qualified healthcare professional.

Is Breast Implant Illness an official diagnosis?

No. FDA states that Breast Implant Illness is a term used to describe systemic symptoms reported by some patients, but it is not currently recognized as a formal medical diagnosis and there are no established diagnostic criteria that definitively define it.

Can symptoms improve after breast implant removal?

Some patients have reported improvement following explantation. FDA has received such reports, but the agency also explains that the cause of systemic symptoms and the degree to which they are related to implants remain unclear.

Is there still a breast implant MDL?

The U.S. District Court for the District of New Jersey maintains the federal Allergan BIOCELL textured breast implant litigation as MDL 2921 and provides the official case-management page for the proceeding.

What records are most important for a breast implant lawsuit?

Important records may include the implant card, manufacturer and model information, serial or lot numbers, operative reports, pathology or biopsy results, oncology records, imaging, explant records, revision surgery records, medical bills, and documents showing lost income or other damages.

How much is a breast implant lawsuit worth?

There is no guaranteed amount. Potential value depends on diagnosis, implant identification, pathology evidence, treatment, surgeries, economic losses, long-term harm, causation evidence, state law, and other individual factors.

Can I estimate my breast implant settlement online?

You can use TortAdvisor’s
Breast Implant Settlement Calculator
as an educational starting point. The result is not a settlement offer, legal valuation, or guarantee of compensation.

Get More Information About a Breast Implant Claim

If you were diagnosed with BIA-ALCL, had a recalled textured implant, underwent explant or major revision surgery, or experienced another serious breast implant complication, gathering your implant and medical records can help with an individual claim review.

About This Guide

This guide was prepared by the TortAdvisor Editorial Team using FDA breast implant safety materials, federal court records, recall information, and other primary sources where available.

This content is for general educational purposes only and is not legal or medical advice. TortAdvisor is not a law firm or healthcare provider. A breast implant, recall, adverse-event report, diagnosis, or pending lawsuit does not automatically establish legal liability or medical causation. Eligibility, filing deadlines, potential compensation, and medical treatment decisions depend on individual circumstances and professional review.